"On Slide 18, Entresto\u00ae continues to deliver 44% full year growth, and the momentum continues across all of the geographies. As you know, we're the only single-use medicine proven to be superior to previous standard of care. And thus, we're in a strong competitive position. It's also great to see that the American College of Cardiologists expert consensus now recommends that heart failure patients go direct to ARNI, and this puts Entresto\u00ae in a pole position for the 75% of patients who are still on standard \u2013 sorry, previous standard of care. We also have exciting opportunities for growth with expansion in China and Japan as well as our life cycle management program for pEF or preserved ejection fraction in post-AMI."